Search results for "Cardiology"

showing 10 items of 6064 documents

Experimentelle Untersuchungen zum Einsatz verschiedener atrialer Dipolkonfigurationen für die Vorhof-Stimulation mit VDD-Elektroden

1998

medicine.medical_specialtybusiness.industryPhysiology (medical)Internal medicinemedicineCardiologyCardiology and Cardiovascular MedicinebusinessCardiac imagingCardiac surgeryHerzschrittmachertherapie und Elektrophysiologie
researchProduct

Förderung und Optimierung der intrinsischen AV-Überleitung bei Patienten mit DDD(R)-Schrittmachern

2000

medicine.medical_specialtybusiness.industryPhysiology (medical)Internal medicinemedicineMEDLINECardiologyCardiology and Cardiovascular MedicinebusinessCardiac imagingCardiac surgeryHerzschrittmachertherapie und Elektrophysiologie
researchProduct

185Effect of gender on patient selection for cardiac resynchronisation therapy

2017

medicine.medical_specialtybusiness.industryPhysiology (medical)MedicineCardiology and Cardiovascular MedicinebusinessIntensive care medicineSelection (genetic algorithm)EP Europace
researchProduct

Aktuelle Ergebnisse der DAVE-Studie, DDD- und VDD-Evaluation: Eine prospektive randomisierte Studie zum Vergleich der DDD- und VDD-Stimulation bei AV…

1998

medicine.medical_specialtybusiness.industryPhysiology (medical)medicineCardiology and Cardiovascular MedicinebusinessNuclear medicineCardiac imagingCardiac surgeryHerzschrittmachertherapie und Elektrophysiologie
researchProduct

Editorial commentary: Sleep disordered breathing and cardiovascular outcomes: is it time to change our thinking?

2017

no abstract

medicine.medical_specialtybusiness.industryPolysomnographySleep apnea030204 cardiovascular system & hematologySettore MED/10 - Malattie Dell'Apparato Respiratoriomedicine.diseaseCardiovascular Systemlaw.inventionSleep apnea Cardiovascular outcomes Randomized controlled trial03 medical and health sciences0302 clinical medicineSleep Apnea Syndromes030228 respiratory systemRandomized controlled triallawSleep disordered breathingPhysical therapyMedicineHumansCardiology and Cardiovascular MedicinebusinessIntensive care medicineCardiovascular outcomes
researchProduct

Response by Núñez et al to Letter Regarding Article, “Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality”

2018

medicine.medical_specialtybusiness.industryPotassiumchemistry.chemical_element030204 cardiovascular system & hematologymedicine.diseaseTerm (time)03 medical and health sciences0302 clinical medicinechemistryPhysiology (medical)Heart failureRisk of mortalitymedicine030212 general & internal medicineCardiology and Cardiovascular MedicineIntensive care medicinebusinessCirculation
researchProduct

INFLUENCE OF RECOMBINANT PRO-UROKINASE ON THE HEMOSTATIC SYSTEM IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION

1987

Recombinant unglycosylated pro-urokinase (recombinant single chain urokinase-type plasminogen activator, CG4509) was given to twelve patients (pts.) with acute myocardial infarction as a 20 mg bolus followed by a 60 mg intravenous infusion (iv.inf.) over 1 hour and to twelve pts. as a 10 mg bolus followed by a 30 mg iv.inf. over 1 hour. Reperfusion was angiographically confirmed in 9/12 pts. with the higher dose and in 6/12 pts. who obtained the lower dose. Different parameters of hemostasis were determined before administration, 30 min after the beginning of inf.,at the end of inf., 60 min thereafter and 6-12 hours afterwards .The most significant systemic changes were observed 60 min afte…

medicine.medical_specialtybusiness.industryPro-urokinasemedicine.diseaselaw.inventionlawInternal medicineparasitic diseasesmedicineRecombinant DNACardiologyIn patientMyocardial infarctionbusinessXIth International Congress on Thrombosis and Haemostasis
researchProduct

CETP levels rather than polymorphisms as markers of coronary risk: Healthy athlete with high HDL-C and coronary disease—effectiveness of probucol

2006

medicine.medical_specialtybusiness.industryProbucolCoronary diseasecoronary diseasepolymorphismcoronary riskCoronary riskInternal medicineCETPCardiologyMedicineHDL-CCardiology and Cardiovascular Medicinebusinessmedicine.drugAtherosclerosis
researchProduct

Serum Heat Shock Protein 60 in Acute Heart Failure: A New Biomarker?

2012

Heat shock protein 60 (HSP60) is a mitochondrial protein constitutively expressed in the majority of cells, and its expression is up-regulated by a variety of stressors. In heart failure, HSP60 is released from cardiomyocytes. The authors speculate that increased serum HSP60 (sHSP60) may be related to the severity of heart failure. This investigation sought to assess the association between sHSP60 and the composite end point of death ⁄ readmission in patients with acute heart failure (AHF). A total of 132 consecutive patients were admitted for AHF. The independent association between sHSP60 and the end point was assessed with Cox regression. During a median follow-up of 7 months (interquart…

medicine.medical_specialtybusiness.industryProportional hazards modelIncidence (epidemiology)Hazard ratioEmergency Nursingmedicine.diseaseConfidence intervalSurgeryInterquartile rangeHeat shock proteinInternal medicineHeart failureEmergency MedicineCardiologymedicineBiomarker (medicine)Cardiology and Cardiovascular MedicinebusinessCongestive Heart Failure
researchProduct

1210Long-term follow-up in the German TRAnscatheter mitral valve Interventions (TRAMI) registry: survival and predictors of mortality

2018

medicine.medical_specialtybusiness.industryPsychological intervention030229 sport sciences030204 cardiovascular system & hematologylanguage.human_languageTerm (time)German03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureMitral valveEmergency medicinelanguagemedicineCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct